跳至主要内容
临床试验/NCT00510172
NCT00510172Unknown不适用

Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2

Glostrup University Hospital, Copenhagen1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2006年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
12
试验地点
1
主要终点
Headache and accompanying symptoms. Blood flow velocity in the middle cerebral artery, diameter changes in superficial temporal artery and radial artery.

研究概览

简要总结

We hypothesised that intravenous infusion of PGI2 induced headache or migraine and cranial vasodilatation in migraineurs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • migraine without aura and healthy apart from that
  • age 18-55 years
  • 50-100 kg
  • Secure contraceptives

排除标准

  • Tension Type Headache more than 3 time a month
  • Other primary headaches
  • Medication prior to the study (closer than 4 times plasma halflife)
  • Migraine or headache 5 days prior to study.
  • Hypertension (systolic BP >150 mmHg and/or diastolic BP >100 mmHg).
  • Hypotension (systolic BP <90 mmHg and/or diastolic BP <50 mmHg).
  • Heart-vessel disease of any kind incl cerebrovascular disease.
  • Anamnestic or clinical signs of psychiatric disease or abuse.
  • Anamnestic or clinical signs of disease of any kind relevant for participation in the study.

研究组 & 干预措施

2

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

1

Active Comparator

Active treatment

干预措施: Prostacyclin, PGI2 (Drug)

结局指标

主要结局

Headache and accompanying symptoms. Blood flow velocity in the middle cerebral artery, diameter changes in superficial temporal artery and radial artery.

时间窗: 14 hours

次要结局

  • Blood pressure, pulse(100 min)

研究者

发起方
Glostrup University Hospital, Copenhagen
申办方类型
Other

研究点 (1)

Loading locations...

相似试验